HomeJhunjhunwala#39;s RARE Trusts-backed Concord Biotech IPO booked 16% on debut Jhunjhunwala#39;s RARE Trusts-backed Concord Biotech IPO booked 16% on debut Innfotainment August 04, 2023 0 Top Post Ad Top Post Responsive Ads code (Google Ads) Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer. http://dlvr.it/StB3CN Below Post Ad Below Post Responsive Ads code (Google Ads) Newer Daily Voice | Focus on midcaps in these 3 key sectors where growth story to continue in future, says this CIO Older India at the start of #39;long wave boom#39;, China#39;s may be ending soon: Morgan Stanley